Side-by-side comparison of AI visibility scores, market position, and capabilities
Parent Unilever 2024: Turnover €60.8B (+1.9%) | Personal Care: €13.6B (+5.2% organic sales growth) | Dove: ~40% of Personal Care, high-single digit growth | Key launches: whole-body deodorant, serum shower collection | Op Profit +12.6% to €11.2B, margin +170bp to 18.4% | H1-Q3 2025: Beauty/Wellbeing +4.1%, Personal Care +5.1% | 2025 target: 3-5% organic sales growth
Dove is a global personal care brand under Unilever offering body wash, beauty bars, deodorants, hair care, and skincare products formulated with moisturizing ingredients and positioned around real beauty and self-esteem. The company serves women, men, and families seeking gentle, nourishing personal care products that respect skin health. Dove differentiates itself through its Real Beauty campaign challenging traditional beauty standards, dermatologist-recommended formulations with 1/4 moisturizing cream, inclusive marketing featuring diverse body types and ages, and commitment to building confidence through the Dove Self-Esteem Project.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.